Cipla Ltd Share Price
(CIPLA)
₹1515.2▲1.26%
as on 04:01PM, 17 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.43 % |
3 Month Return | + 4.83 % |
1 Year Return | + 12.46 % |
Market Stats | |
Previous Close | ₹1,496.40 |
Open | ₹1,498.00 |
Volume | 12.12L |
Upper Circuit | ₹1,646.00 |
Lower Circuit | ₹1,346.80 |
Market Cap | ₹1,22,370.15Cr |
P/E Ratio
24.52
PEG Ratio
1.55
Market Cap
₹1,22,370.15 Cr
P/B Ratio
4.31
EPS
51.47
Dividend Yield
0.87
Sector
Pharmaceuticals
ROE
15.5
based on 37 analysts
64.86%
Buy
21.62%
Hold
13.51%
Sell
Based on 37 analysts offering long term price targets for Cipla. An average target of ₹1642.27
Source: S&P Global Market Intelligence
Cipla price forecast by 37 analysts
Upside of8.39%
High
₹1875
Target
₹1642.27
Low
₹1204
Cipla target price ₹1642.27, a slight upside of 8.39% compared to current price of ₹1515.2. According to 37 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Cipla revenue growth forecast
Expected growth rate Q1, FY2027:24.56%
Forecast
Actual
Including amortisation and stock based compensations
Cipla EPS growth forecast
EPS estimate Q1, FY2027:30.42%
Forecast
Actual
Source: S&P Global Market Intelligence
Nomura Reaffirms Buy Rating on Cipla with Target Price - 14 Apr, 2025
Cipla Secures USFDA Approval for Generic Cancer Drug - 11 Apr, 2025
Cipla Secures FDA Approval and Announces Earnings Date - 10 Apr, 2025
Cipla Reports Strong Q3 FY25 Financial Results - 08 Apr, 2025
Cipla Faces Pressure Amid Pharma Index Decline - 07 Apr, 2025
Cipla Shares Plummet Amid Tariff Concerns - 04 Apr, 2025
Cipla Shares Surge After U.S. Tariff Exemption - 03 Apr, 2025
Concerns Over US Tariffs Impacting Indian Pharma - 30 Mar, 2025
Cipla's Nifty Weightage Increase Expected - 26 Mar, 2025
Cipla Positioned for Growth Amid Challenges - 22 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 939.04 Cr → 1.57K Cr (in ₹), with an average increase of 15.6% per quarter
MF Holding Up
Mutual Funds have increased holdings from 17.44% to 20.42% in Dec 2024 quarter
Revenue Rich
Revenue is up for the last 4 quarters, 6.41K Cr → 7.29K Cr (in ₹), with an average increase of 4.2% per quarter
Price Rise
In the last 3 months, CIPLA stock has moved up by 4.8%
Retail Holding Up
Retail Investor have increased holdings from 16.08% to 16.41% in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 52.1% return, outperforming this stock by 39.6%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.1% return, outperforming this stock by 80.7%
Promoter Holding Down
Promoters have decreased holdings from 30.86% to 29.13% in Dec 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 28.74% to 26.60% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 29.13% | ||
Foreign Institutions | 26.6% | ||
Mutual Funds | 20.42% | 17.09 | |
Retail Investors | 16.41% | 2.06 | |
Others | 7.44% | 8.01 |
Cipla in the last 5 years
Lowest (18.11x)
March 19, 2020
Today (24.52x)
April 17, 2025
Industry (53.02x)
April 17, 2025
Highest (42.80x)
January 23, 2018
Cipla Ltd’s net profit jumped 48.74% since last year same period to ₹1,570.51Cr in the Q3 2024-2025. On a quarterly growth basis, Cipla Ltd has generated 20.57% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Cipla Ltd has declared dividend of ₹13 - translating a dividend yield of 1.42%.
Read More about DividendsBearish
Neutral
Bullish
Cipla Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹1,22,370.15 Cr | 31.77% | 0.50 | ₹4,155 Cr | ₹25,774 Cr | |
HOLD | ₹1,49,724.28 Cr | 28.15% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
BUY | ₹1,10,152.27 Cr | 35.85% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
BUY | ₹39,775.88 Cr | -1.49% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
HOLD | ₹23,879.80 Cr | -4.07% | 0.50 | ₹772 Cr | ₹5,664 Cr |
Organisation | Cipla |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Cipla Ltd share price today stands at ₹1515.2, Open: ₹1498, Previous Close: ₹1496.4, High: ₹1522, Low: ₹1486, 52 Week High: ₹1702.05, 52 Week Low: ₹1317.25.
Today's traded volume of Cipla Ltd(CIPLA) is 12.12L.
Today's market capitalisation of Cipla Ltd(CIPLA) is ₹122370.15Cr.
Cipla Ltd (CIPLA) share price is ₹1515.2. It is down -10.98% from its 52 Week High price of ₹1702.05
Cipla Ltd (CIPLA) share price is ₹1515.2. It is up 15.03% from its 52 Week Low price of ₹1317.25